FDA Breakthrough Therapy

Business

Tesla Gets a Boost: TD Cowen Raises Price Target to $519, Citing Mixed Q4 Signals

Investment firm TD Cowen has increased its price target on Tesla (TSLA) to $519, maintaining a Buy rating. The adjustment follows a fourth-quarter performance marked by strong margins and progress on autonomous driving projects, though tempered by higher capital expenditure forecasts and vague timelines for full self-driving technology.

Jan 30, 2026

Business

U.S. Regulators and Lawmakers Signal Major Shift Toward Crypto Framework

In a landmark day for digital asset policy, U.S. regulators unveiled a coordinated initiative while a key Senate committee advanced market structure legislation, signaling a potential end to years of regulatory uncertainty.

Jan 30, 2026

Business

GCL Global Posts Soaring Revenue on Acquisition, But Swings to Loss Amid Integration Costs

GCL Global's fiscal first-half revenue nearly doubled after consolidating Ban Leong Technologies, yet the company reported a net loss as it absorbed acquisition costs. Management lowered full-year guidance, citing delays for two key game titles.

Jan 30, 2026

Business

Adyen Doubles Down on Strategic Partnerships Amid Stock Slump, Expanding U.S. Benefit Access and Asia-Pacific Footprint

Dutch payments giant Adyen is forging ahead with two key partnerships—enabling SNAP EBT payments in the U.S. with Forage and launching embedded solutions in Asia-Pacific with Raptor—as it seeks to reignite growth while its shares languish well below historic highs.

Jan 30, 2026

Business

Cathie Wood Sees Buying Opportunity in Market Dip, Adds to Stakes in Joby, Kodiak AI, and CRISPR

ARK Invest's founder capitalized on recent market weakness to increase holdings in three of her flagship disruptive innovation picks, signaling continued conviction despite sector volatility.

Jan 30, 2026

Business

Nvidia Aided China's DeepSeek In Advancing Powerful AI Models Later Linked To Military Use, House Committee Chair Alleges: Report

A U.S. lawmaker has alleged that Nvidia Corp (NASDAQ:NVDA) provided technical assistance to Chinese AI startup DeepSeek. Nvidia Technical Support Allegedly Boosted DeepSeek's Efficiency Nvidia helped DeepSeek improve the efficiency of its artificial intelligence models, according to a letter sent to the U.S. Commerce Department by Rep. John Moolenaar (R-Mich.), chair of the House Select Committee on China. The letter, seen by Reuters on Wednesday, says documents obtained by the committee show th

Jan 30, 2026

World

Remains and Jacket Discovered in Tasmanian Wilderness, Likely Ending Two-Year Search for Missing Belgian Hiker

Tasmanian police believe they have found the remains of Celine Cremer, a Belgian hiker missing since 2023, along with clothing items including a polar fleece jacket, following a renewed search near Philosopher's Falls.

Jan 30, 2026

World

Putin Agrees to Trump's Request for Temporary Halt on Kyiv Strikes, Kremlin Confirms

The Kremlin stated President Vladimir Putin has agreed to a personal appeal from former U.S. President Donald Trump to pause strikes on Kyiv until February 1, aiming to foster conditions for potential talks, though the scope and durability of the pause remain unclear.

Jan 30, 2026

Business

Lilly Bets Big on Repertoire's Immune Decoding Tech in Up to $1.9B Autoimmune Pact

Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.

Jan 30, 2026

World

Taiwan completes first undersea trial for domestically made submarine

TAIPEI, Jan 30 (Reuters) - Taiwan completed the maiden underwater sea trial for its first domestically developed submarine on Thursday, a big milestone in a project aimed at strengthening deterrence

Jan 30, 2026

World

Russian Forces Advance in Eastern Ukraine, Seize Three Villages in Donetsk and Zaporizhzhia

Russian troops have taken control of three villages across Ukraine's Donetsk and Zaporizhzhia regions, according to a Defense Ministry statement reported by state media. The latest gains come amid intensified fighting along the front lines.

Jan 30, 2026

Business

ResMed Founder's Prestigious Honor Casts Spotlight on Company's Enduring Growth Narrative

The Horatio Alger Award bestowed upon ResMed founder Dr. Peter Farrell underscores the company's decades-long leadership in sleep and respiratory care, bringing its financial performance and competitive strategy into sharper focus for investors.

Jan 30, 2026

Business

DuPont Unveils AmberLite FPA57 Resin, Targeting Efficiency Gains in Key Industries

DuPont de Nemours launches a new ion exchange resin designed to boost productivity for organic acid producers in food, pharma, and bioplastics, as its stock shows sustained momentum.

Jan 30, 2026

Business

Genmab Shares Face Target Cut After EPKINLY Trial Misses Survival Goal, But Analysts Keep Faith

H.C. Wainwright has trimmed its price target on Genmab following mixed Phase 3 results for its lymphoma drug EPKINLY, though maintains a Buy rating, citing precedent and ongoing trials.

Jan 30, 2026

Business

Amprius Technologies: Battery Innovator or Overheated Stock?

Amprius Technologies' shares have skyrocketed over 300% in the past year, driven by excitement around its silicon-anode battery technology. However, a deep dive into the company's financials reveals a significant valuation gap, raising questions about whether the stock's momentum has outpaced its fundamentals.

Jan 30, 2026

Business

Altria Navigates Smoke-Free Shift Amid Illicit Vape Headwinds, Posts Steady Growth

Altria Group reported adjusted earnings growth and robust shareholder returns for 2025, even as it grapples with a rapidly transforming nicotine market dominated by illicit flavored vapes and intense competition in oral tobacco.

Jan 30, 2026

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Business

Bank of America Bullish on Apellis, Upgrades to 'Buy' on Strong Drug Launch and Kidney Disease Prospects

Bank of America has upgraded Apellis Pharmaceuticals (APLS) to 'Buy,' citing robust early adoption of its drug Empaveli and significant undervaluation of its potential in treating rare kidney diseases, despite a more cautious outlook from Wells Fargo.

Jan 30, 2026

Business

BD Strikes Waters Deal and Advances Medical Plastics Recycling in Strategic Overhaul

Becton Dickinson announces a major spin-off of its Biosciences unit to combine with Waters Corporation, alongside a successful pilot to recycle polystyrene labware, signaling a dual push towards portfolio focus and sustainability.

Jan 30, 2026

Business

Nvidia's AI Bet: A Bargain Amidst Soaring Industry Spending?

Despite a flat start to 2026, Nvidia's valuation appears compelling as new forecasts project global AI spending to surge past $3.3 trillion by 2027, suggesting the chipmaker's growth story is far from over.

Jan 30, 2026